Go to Top

Taking a Personal Approach to Cancer

Men Cancer Worldwide Spread

men_cancer_world_eng

Women Cancer Worldwide Spread

women cancer map
Genomic tests have opened many possibilities for researchers and oncologists to analyze the genetic makeup of tumors. In breast cancer for example, only a couple of years ago researchers knew of only two most common heredity genes, now there are around twenty five and presumably many more to discover.

Oncologists used to treat cancer patients according to the disease and did not take a personal approach to each patient. The issue of personalized medicine is a developing practice that tackles a patent’s genetic profile to diagnose, prevent and treat diseases such as cancer.

Personalized oncology is the most advanced method today to treat cancer. This is where future medicine is heading to, to be able to treat people according to their genome and to provide the exact medicine or treatment which will help them recover. The approach of one size fits all is not acceptable today in the field of medicine.

The research on the genome will be able to assist us not only in receiving the right treatment but also in preventative measures. We will probably be able to reduce the risk of getting the disease in the future if we know that we are likely to get it.

A deep gene sequencing of tumors will provide cancer patients the best medication suitable for them, based on how the tumor will respond to the treatment. Very early in the treatment the oncologist will know if the medication treatment will be responsive or not, which will save time in applying the right medication and will change the prognosis for the better in most cases. Researches will work on preventative medicine and you may only be taking a daily tablet in order to fight potential cancer.

There is no question to the fact that the research of cancer has made a very impressive progress in the last five years. The genetic decoding has made a breakthrough in all the research of many diseases. The genetic structure of the patient will determine the treatment.

All cancer patients usually receive the same treatment which includes chemotherapy and radiation, which lowers the mortality rate. For lung cancer patients, mapping will ensure if the patient has a gene which is common in 30% of the patients with lung cancer (EGFR) and receives a special drug for that type of cancer but if the patient does not carry this gene, a different drug will be administered.

The key to genomic studies is not just sequencing, but analyzing the data. Studies will focus on unraveling the genetic signature of cancer, and this will extend to reveal other diseases as the researches build greater genomic capabilities.

The cost of genomic sequencing has come down significantly. Six years ago, it cost a fortune to perform a whole genome sequencing on a few patients. Today the cost is down and sequencing can be performed in days. This enables researchers to now use sequencing to measure tumor-specific alterations.

Melanoma is a form of skin cancer, the treatment of which has had successful results since the MRI was founded. Many research institutes are focusing on the genetic drivers of this cancer which is one of the fastest growing cancers in the Western world, to enable patients with melanoma and all its subtypes to receive a personalized treatment.

Today, you can find diagnostic institutes that not only perform a biopsy, endoscopic tests and imaging scans but also a test of the genetics of the tumor; after all diagnostic examinations, a multidisciplinary team of doctors tailor a treatment which is the best option for the patient.